There are 2789 resources available
1257P - Effect of hepatic impairment on tepotinib pharmacokinetics
Presenter: Thomas Marbury
Session: ePoster Display
1258P - MET exon14 skipping in non-small cell lung cancer: Clinicopathological characteristics, treatments, and efficacy of crizotinib according to functional analysis: AFonMET - GFPC study
Presenter: Hélène Babey
Session: ePoster Display
1259P - Real-world next-generation sequencing (NGS) and treatment (Tx) patterns in non-small cell lung cancer (NSCLC) patients (pts) with MET exon 14 skipping mutations (METex14)
Presenter: Xiuning Le
Session: ePoster Display
371P - Low-dose bevacizumab for the treatment of focal post-radiation necrosis of the brain
Presenter: Jens Tijtgat
Session: ePoster Display
372P - The prognostic value of liver metastases and how affects the applicability of the lung-molGPA in non-small cell lung cancer patients with brain metastases
Presenter: Joel Rafael Veas Rodriguez
Session: ePoster Display
373P - Brain metastases: Extracranial disease status as a prognostic factor after whole brain radiotherapy. Results from a prospective, population-based study
Presenter: Olav Yri
Session: ePoster Display
374P - A real-world application of aqueous humor and vitreous fluid for the diagnosis of vitreoretinal lymphoma and treatment monitoring
Presenter: Xiaoxiao Wang
Session: ePoster Display
375P - Clinical outcomes of targeting therapy with BRAF/MEK inhibitors in patients with BRAF V600-mutated brain tumors
Presenter: Marta Mejías Trueba
Session: ePoster Display
376P - Nucleolin and its prognostic value in pediatric patients with intracranial ependymoma: A systematic review and meta-analysis
Presenter: Jeremiah Wijaya
Session: ePoster Display
377P - Comparison of current guidelines and real-world evidence data for the treatment of glioblastoma across Europe
Presenter: Carrmen Escorial
Session: ePoster Display